Vanberra Signal

Dosis

Curated by Signal

Provider of clinical decision support tool for clinicians

Overview

Dosis provides a clinical decision support tool for healthcare professionals. The company uses AI and control algorithms to measure the anemic patient's prior Hb levels and ESA (erythropoietin stimulating agents) doses for giving insights in fixing the dosage amount for a particular individual. Their platform SAA (Strategic Anemic Advisor) can fix doses for antidiabetic agents, anticonvulsants, antiarrhythmic agents, and antihypertensive agents. It also offers clinical data to aid in their decision support for better health outcomes.

Key facts

Founded
2017

Business model

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Health Technology companies
  • AI-based medication management tool for patients

    Health TechnologyUnited States
  • Mobile application to search for blood donation drives

    Health TechnologyMclean, United States

About Dosis

What does Dosis do?

Dosis provides a clinical decision support tool for healthcare professionals.

Where is Dosis headquartered?

Dosis is headquartered in San Francisco, United States.

When was Dosis founded?

Dosis was founded in 2017.

Which sector is Dosis in?

Dosis operates in Health Technology.

Who are Dosis's competitors?

Companies similar to Dosis include Mednovate Connect, Blood Donor Mobile, and One Step Software Solutions.